Cargando…

Prognostic Value of the New Prostate Cancer International Society of Urological Pathology Grade Groups

Gleason grading is the best independent predictor for prostate cancer (PCa) progression. Recently, a new PCa grading system has been introduced by the International Society of Urological Pathology (ISUP) and is recommended by the World Health Organization (WHO). Following studies observed more accur...

Descripción completa

Detalles Bibliográficos
Autores principales: Offermann, Anne, Hohensteiner, Silke, Kuempers, Christiane, Ribbat-Idel, Julika, Schneider, Felix, Becker, Finn, Hupe, Marie Christine, Duensing, Stefan, Merseburger, Axel S., Kirfel, Jutta, Reischl, Markus, Lubczyk, Verena, Kuefer, Rainer, Perner, Sven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5626925/
https://www.ncbi.nlm.nih.gov/pubmed/29034236
http://dx.doi.org/10.3389/fmed.2017.00157
_version_ 1783268625777426432
author Offermann, Anne
Hohensteiner, Silke
Kuempers, Christiane
Ribbat-Idel, Julika
Schneider, Felix
Becker, Finn
Hupe, Marie Christine
Duensing, Stefan
Merseburger, Axel S.
Kirfel, Jutta
Reischl, Markus
Lubczyk, Verena
Kuefer, Rainer
Perner, Sven
author_facet Offermann, Anne
Hohensteiner, Silke
Kuempers, Christiane
Ribbat-Idel, Julika
Schneider, Felix
Becker, Finn
Hupe, Marie Christine
Duensing, Stefan
Merseburger, Axel S.
Kirfel, Jutta
Reischl, Markus
Lubczyk, Verena
Kuefer, Rainer
Perner, Sven
author_sort Offermann, Anne
collection PubMed
description Gleason grading is the best independent predictor for prostate cancer (PCa) progression. Recently, a new PCa grading system has been introduced by the International Society of Urological Pathology (ISUP) and is recommended by the World Health Organization (WHO). Following studies observed more accurate and simplified grade stratification of the new system. Aim of this study was to compare the prognostic value of the new grade groups compared to the former Gleason Grading and to determine whether re-definition of Gleason Pattern 4 might reduce upgrading from prostate biopsy to radical prostatectomy (RP) specimen. A cohort of men undergoing RP from 2002 to 2015 at the Hospital of Goeppingen (Goeppingen, Germany) was used for this study. In total, 339 pre-operative prostatic biopsies and corresponding RP specimens, as well as additional 203 RP specimens were re-reviewed for Grade Groups according to the ISUP. Biochemical recurrence-free survival (BFS) after surgery was used as endpoint to analyze prognostic significance. Other clinicopathological data included TNM-stage and pre-operative PSA level. Kaplan–Meier analysis revealed risk stratification of patients based on both former Gleason Grading and ISUP Grade Groups, and was statistically significant using the log-rank test (p < 0.001). Both grading systems significantly correlated with TNM-stage and pre-operative PSA level (p < 0.001). Higher tumor grade in RP specimen compared to corresponding pre-operative biopsy was observed in 44 and 34.5% of cases considering former Gleason Grading and ISUP Grade Groups, respectively. Both, former Gleason Grading and ISUP Grade Groups predict survival when applied on tumors in prostatic biopsies as well as RP specimens. This is the first validation study on a large representative German community-based cohort to compare the former Gleason Grading with the recently introduced ISUP Grade Groups. Our data indicate that the ISUP Grade Groups do not improve predictive value of PCa grading and might be less sensitive in deciphering tumors with 3 + 4 and 4 + 3 pattern on RP specimen. However, the Grade Group system results less frequently in an upgrading from biopsy to the corresponding RP specimens, indicating a lower risk to miss potentially aggressive tumors not represented on biopsies.
format Online
Article
Text
id pubmed-5626925
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-56269252017-10-13 Prognostic Value of the New Prostate Cancer International Society of Urological Pathology Grade Groups Offermann, Anne Hohensteiner, Silke Kuempers, Christiane Ribbat-Idel, Julika Schneider, Felix Becker, Finn Hupe, Marie Christine Duensing, Stefan Merseburger, Axel S. Kirfel, Jutta Reischl, Markus Lubczyk, Verena Kuefer, Rainer Perner, Sven Front Med (Lausanne) Medicine Gleason grading is the best independent predictor for prostate cancer (PCa) progression. Recently, a new PCa grading system has been introduced by the International Society of Urological Pathology (ISUP) and is recommended by the World Health Organization (WHO). Following studies observed more accurate and simplified grade stratification of the new system. Aim of this study was to compare the prognostic value of the new grade groups compared to the former Gleason Grading and to determine whether re-definition of Gleason Pattern 4 might reduce upgrading from prostate biopsy to radical prostatectomy (RP) specimen. A cohort of men undergoing RP from 2002 to 2015 at the Hospital of Goeppingen (Goeppingen, Germany) was used for this study. In total, 339 pre-operative prostatic biopsies and corresponding RP specimens, as well as additional 203 RP specimens were re-reviewed for Grade Groups according to the ISUP. Biochemical recurrence-free survival (BFS) after surgery was used as endpoint to analyze prognostic significance. Other clinicopathological data included TNM-stage and pre-operative PSA level. Kaplan–Meier analysis revealed risk stratification of patients based on both former Gleason Grading and ISUP Grade Groups, and was statistically significant using the log-rank test (p < 0.001). Both grading systems significantly correlated with TNM-stage and pre-operative PSA level (p < 0.001). Higher tumor grade in RP specimen compared to corresponding pre-operative biopsy was observed in 44 and 34.5% of cases considering former Gleason Grading and ISUP Grade Groups, respectively. Both, former Gleason Grading and ISUP Grade Groups predict survival when applied on tumors in prostatic biopsies as well as RP specimens. This is the first validation study on a large representative German community-based cohort to compare the former Gleason Grading with the recently introduced ISUP Grade Groups. Our data indicate that the ISUP Grade Groups do not improve predictive value of PCa grading and might be less sensitive in deciphering tumors with 3 + 4 and 4 + 3 pattern on RP specimen. However, the Grade Group system results less frequently in an upgrading from biopsy to the corresponding RP specimens, indicating a lower risk to miss potentially aggressive tumors not represented on biopsies. Frontiers Media S.A. 2017-09-29 /pmc/articles/PMC5626925/ /pubmed/29034236 http://dx.doi.org/10.3389/fmed.2017.00157 Text en Copyright © 2017 Offermann, Hohensteiner, Kuempers, Ribbat-Idel, Schneider, Becker, Hupe, Duensing, Merseburger, Kirfel, Reischl, Lubczyk, Kuefer and Perner. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Offermann, Anne
Hohensteiner, Silke
Kuempers, Christiane
Ribbat-Idel, Julika
Schneider, Felix
Becker, Finn
Hupe, Marie Christine
Duensing, Stefan
Merseburger, Axel S.
Kirfel, Jutta
Reischl, Markus
Lubczyk, Verena
Kuefer, Rainer
Perner, Sven
Prognostic Value of the New Prostate Cancer International Society of Urological Pathology Grade Groups
title Prognostic Value of the New Prostate Cancer International Society of Urological Pathology Grade Groups
title_full Prognostic Value of the New Prostate Cancer International Society of Urological Pathology Grade Groups
title_fullStr Prognostic Value of the New Prostate Cancer International Society of Urological Pathology Grade Groups
title_full_unstemmed Prognostic Value of the New Prostate Cancer International Society of Urological Pathology Grade Groups
title_short Prognostic Value of the New Prostate Cancer International Society of Urological Pathology Grade Groups
title_sort prognostic value of the new prostate cancer international society of urological pathology grade groups
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5626925/
https://www.ncbi.nlm.nih.gov/pubmed/29034236
http://dx.doi.org/10.3389/fmed.2017.00157
work_keys_str_mv AT offermannanne prognosticvalueofthenewprostatecancerinternationalsocietyofurologicalpathologygradegroups
AT hohensteinersilke prognosticvalueofthenewprostatecancerinternationalsocietyofurologicalpathologygradegroups
AT kuemperschristiane prognosticvalueofthenewprostatecancerinternationalsocietyofurologicalpathologygradegroups
AT ribbatideljulika prognosticvalueofthenewprostatecancerinternationalsocietyofurologicalpathologygradegroups
AT schneiderfelix prognosticvalueofthenewprostatecancerinternationalsocietyofurologicalpathologygradegroups
AT beckerfinn prognosticvalueofthenewprostatecancerinternationalsocietyofurologicalpathologygradegroups
AT hupemariechristine prognosticvalueofthenewprostatecancerinternationalsocietyofurologicalpathologygradegroups
AT duensingstefan prognosticvalueofthenewprostatecancerinternationalsocietyofurologicalpathologygradegroups
AT merseburgeraxels prognosticvalueofthenewprostatecancerinternationalsocietyofurologicalpathologygradegroups
AT kirfeljutta prognosticvalueofthenewprostatecancerinternationalsocietyofurologicalpathologygradegroups
AT reischlmarkus prognosticvalueofthenewprostatecancerinternationalsocietyofurologicalpathologygradegroups
AT lubczykverena prognosticvalueofthenewprostatecancerinternationalsocietyofurologicalpathologygradegroups
AT kueferrainer prognosticvalueofthenewprostatecancerinternationalsocietyofurologicalpathologygradegroups
AT pernersven prognosticvalueofthenewprostatecancerinternationalsocietyofurologicalpathologygradegroups